Liquid Nitrogen

Quick links to important sections

Liquid Nitrogen

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Liquid Nitrogen

Property Description
Active ingredient Nitrogen (N2)
Form Topical preparation (Cryogenic Liquid)
Pharmacological class Cryotherapeutic Agent / Tissue Destructive Agent
Common Use Targeted elimination of abnormal skin tissue
Origin Derived (Physical state transformation)

What is Liquid Nitrogen and How is it Classified?

Liquid Nitrogen (LN2) is defined as a unique topical preparation—a specialized cryogenic liquid—used in controlled medical environments, classifying it as a potent cryotherapeutic agent. Its placement in the pharmacological landscape is as a Tissue Destructive Agent because its therapeutic effect is achieved entirely through extreme physical energy, rather than typical chemical or biological pharmacology. This agent is administered topically and derives its identity from its physical property: an ultra-low temperature of approximately -196°C (-320°F). Its efficacy for targeted lesion removal is widely recognized within dermatological practice, supported by a long history of clinical application.


Composition, Origin, and Action Principle

Liquid Nitrogen is a single-ingredient product where the active component is the element Nitrogen (N2), converted to its liquid state for therapeutic use. It is classified as a derived substance, not a traditionally manufactured synthetic or plant-based compound, as its efficacy stems solely from its physical state transformation. Notably, Liquid Nitrogen contains no traditional base, vehicle, or excipients; the cryogenic liquid itself acts as the singular active ingredient and dispensing medium. The core action principle is cryodestruction, which involves the rapid formation of ice crystals within targeted cells, causing immediate thermal injury. This mechanism is crucial for treating skin conditions, as cryosurgery utilizes the destructive power of cold to safely remove lesions.


What is the General Purpose of This Cryosurgical Agent?

The general purpose of this cryosurgical agent is to achieve the precise and controlled elimination or modification of undesirable or abnormal tissue. The benefit of this method is that it offers a non-incisional, physical approach to tissue removal by utilizing the extreme cold to selectively destroy cells. This targeted destruction via rapid tissue freezing allows the practitioner to precisely address the area of concern, supporting the general therapeutic goal of clearing abnormal skin growths through a defined process of freezing and subsequent removal.

Regulatory References

  1. Cryotherapy in Dermatology

What side effects are possible with Liquid Nitrogen?

Possible Side Effects and Safety Information

Official government regulatory bodies characterize the safety profile of Liquid Nitrogen primarily by its inherent physical hazards as a cryogenic agent, not by conventional pharmacological adverse reaction frequencies.

Documented Adverse Reactions and Hazards

The most serious safety concerns documented in regulatory sources fall into three primary categories:

  • Cryogenic Injury: Direct contact with the liquid or cold vapor can cause rapid, severe tissue damage, including frostbite, cold burns, and necrosis leading to permanent injury or loss of tissue. Contact with the eyes poses a risk of permanent blindness.
  • Asphyxiation: When the liquid evaporates, it produces a large volume of nitrogen gas, rapidly displacing oxygen in the surrounding air. In confined or poorly ventilated spaces, this can lead to unconsciousness, anoxia, and death.
  • Internal Organ Damage (Ingestion): Specific safety advisories note the severe, potentially fatal risk of internal perforation and significant gastrointestinal tissue damage from ingesting or consuming food/drink where the liquid or undissipated liquid residue is still present.

Safety-Related Restrictions and Limitations

The risk assessment requires specific limitations on use:

  • Ventilation: Use must be strictly limited to well-ventilated areas to mitigate the life-threatening risk of oxygen displacement.
  • Container Safety: Storage and transport containers must never be sealed to prevent rapid pressure build-up, which carries a significant hazard of vessel rupture or explosion.
  • Consumer Safety: In the context of food and beverage preparation, official restrictions are in place to prevent the serving of products that contain the substance to consumers, due to the severe internal injury risk. Patients with asthma may face increased risk from inhaling vapors.

Overdose and Emergency Response

Overdose and when to seek help

Overexposure to this cryotherapeutic agent is defined by severe physical hazards rather than systemic pharmacology. Documented presentations of overexposure include cryogenic burns or injury and frostbite to the skin and eyes, representing severe local tissue damage. The other critical hazard is Asphyxiation, with symptoms like dizziness and loss of consciousness, which occurs if the liquid nitrogen vapor displaces oxygen in a confined space. This systemic risk of asphyxiation carries a classification of Risk of death in official documentation.


Immediate Action and Required Medical Attention

Prompt medical attention is mandatory in all cases of overexposure, including instances of frostbite or eye contact. There is no specific antidote known for the effects of overexposure; management is solely symptomatic. Officially described emergency actions include the immediate removal of the exposed person to uncontaminated fresh air, followed by administering supplemental oxygen or artificial respiration if breathing is difficult. For local injury, affected parts must be thawed with lukewarm water (40 C to 42 C), and the area must not be rubbed. Individuals with existing respiratory conditions, such as asthma, are noted to have a potential for increased difficulty breathing upon vapor inhalation.

Therapeutic Uses of Liquid Nitrogen

What Liquid Nitrogen Treats: Main Uses and Benefits

Liquid Nitrogen cryotherapy is an established dermatological intervention used within therapeutic contexts requiring the addressing of abnormal tissue. It is employed for a wide range of skin conditions, supporting therapeutic management.

This agent is commonly used to help address precancerous skin lesions like Actinic Keratosis, which are characterized by rough, scaly patches. This application supports the clinical benefit in contexts of potential malignant progression by addressing the abnormal tissue. It is also used to support the clearance of Common Warts, Seborrheic Keratosis, and Molluscum Contagiosum. It addresses symptom patterns characterized by localized epidermal growth or persistent, cosmetically undesirable lesions.

Non-Surgical Utility and Patient Support

The treatment approach offers distinct utility by providing a non-surgical method for tissue removal, appealing to patients who are poor surgical candidates or require support in facilitating a swift return to routine. This approach is generally relevant for easing physical discomfort and may help facilitate a faster return to routine.

“This technique is generally associated with a supportive aesthetic result.”

Quick Fact: Relevant for addressing Localized Epidermal Growths

Regulatory References

  1. NHS Patient Information

Eligibility and Restrictions for Use

Official Eligibility and Contraindications for Liquid Nitrogen Cryotherapy

Regulatory and public health guidelines establish clear eligibility criteria for the use of Liquid Nitrogen (LN2) as a cryotherapeutic agent, focusing primarily on patient conditions that interact negatively with extreme cold or impair localized tissue healing.

Contraindicated Populations (Must Not Use)

Absolute contraindications are in place for patients with conditions exacerbated by cold, including Cold Urticaria, Cryoglobulinemia, and severe Raynaud's Disease. Treatment is also prohibited for any lesion that has not been definitively diagnosed and for applications in areas with compromised circulation or poor vascular supply, which risks serious complications.

Conditional and Permitted Use

Use is permitted for Adults and Older Adults, and is generally considered safe during pregnancy and breastfeeding due to the agent's non-systemic, topical nature. Caution is required for patients with Diabetes when treating lower extremities, and for very young children, where use is restricted due to concerns over pain tolerance and cooperation.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Liquid Nitrogen (LN₂), a specialized cryotherapeutic agent, functions entirely via its extreme physical property (ultra-low temperature) to achieve localized tissue destruction. This mode of action is non-systemic; the agent does not undergo metabolism and is not absorbed into the bloodstream. Consequently, the official regulatory profile for this product is defined by the absence of traditional systemic interaction data.

Official Interaction Statements

Regulatory documents, such as the prescribing information filed with the U.S. Food and Drug Administration (FDA) through DailyMed, do not include a dedicated section on Drug Interactions.

  • No specific medicinal products or product categories are formally listed as contraindicated for co-administration based on a chemical or pharmacological interaction risk.
  • The label does not document any interactions involving metabolic enzymes (e.g., CYP450) or drug transporters.
  • There are no official timing-based rules or separation requirements mandated due to a formal drug interaction risk.
  • Interactions with food, alcohol, or dietary supplements are not specified in the regulatory information.

Connection to the overall interaction profile

The overall interaction structure confirms that no restrictions, contraindications, or specific dosing adjustments related to pharmacokinetic or pharmacodynamic interactions with other medicines are required by regulatory authorities. This lack of documented systemic interaction is intrinsic to the agent’s physical mode of action, which eliminates the basis for traditional drug-drug interactions.

Mechanism of Action

Direct Cellular Cryo-Injury and Osmotic Disruption

This domain covers the immediate physical interaction of the ultra-low temperature with the cellular structure, primarily targeting cellular water and the cell plasma membrane. The rapid freezing induces a severe osmotic gradient, causing catastrophic cellular dehydration, while the formation of intracellular ice crystals physically breaches the cell and mitochondrial membranes. The resulting cascade leads to irreversible structural damage and initiates cell death, contributing to the overall destructive consequence.


Secondary Microvascular Ischemia and Necrosis

This secondary domain focuses on the downstream physiological failure of the localized blood supply, which complements the primary cryo-injury. The thermal shock damages the endothelial cells of the microvasculature, leading to localized platelet aggregation and the formation of microthrombi. This mechanism results in complete vascular stasis and subsequent ischemic necrosis, which causes the destruction of any cells surviving the initial freeze-thaw cycle and contributes to localized tissue destruction.

Dosage and Administration Information

Instruction Map: How to Use Nitrogen, NF — Official Administration Guidelines

Nitrogen, NF (National Formulary) is a human prescription drug classified as a medical gas. Its administration is strictly controlled and must comply with specific procedural and handling requirements defined in regulatory labeling.


Administration Scope

Feature Official Instruction
Route of Administration RESPIRATORY (INHALATION) for the compressed gas form; Topical/Local Application (e.g., cryosurgery) for the refrigerated liquid form.
Dosing Schedule Dosage, method, frequency, and duration of administration are determined by the licensed practitioner who is experienced in the use of Nitrogen. No fixed standard dosage is provided on the product label.
Preparation Requirements Use only with equipment rated for cylinder pressure and install a back flow preventive device in the piping. The cylinder valve must not be opened until connected to equipment prepared for use.
Age-Group Rules The product is restricted to use only by or under the supervision of a licensed practitioner; no specific pediatric or geriatric dosage adjustments are detailed on the label.

Special Procedural Conditions

Handling Requirements for Refrigerated Liquid:

  • For liquid withdrawal, the user must wear a face shield and gloves.
  • Containers must always be kept in the upright position.
  • The cylinder temperature must not be allowed to exceed 52°C (125°F).
  • The valve must be closed after each use and when empty.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Liquid Nitrogen

Evidence Base for Actinic Keratosis Studies

Research has explored the use of cryotherapy for conditions like Actinic Keratosis, utilizing Randomized Controlled Trials (RCTs) and Prospective Cohort Studies that evaluated protocols against various topical prescription therapies. These studies monitored measurements of lesion status in adults and older adults. Findings suggest that outcomes were associated with the specific application technique used, indicating that technical factors influence the patterns observed. Research is ongoing, and the overall certainty remains low regarding a single standardized, optimal application protocol, as evidence quality varies due to these technical factors.


Evidence Base for Common Warts Studies

Liquid Nitrogen was studied for addressing Common Warts through large-scale Systematic Reviews and RCTs designed to compare protocols against standard non-prescription topical treatments like salicylic acid. Studies monitored outcomes related to lesion status in children and adults. Findings indicate that reported measurements of clearance were observed in some studies to be comparable to non-prescription topical options. However, due to high heterogeneity in trial designs, comparative evidence is lacking regarding a consistent measurement of higher effectiveness compared to other evaluated treatments.


Evidence Base for Seborrheic Keratosis Studies

The use of this treatment was evaluated in research exploring conditions characterized by benign growths known as Seborrheic Keratosis. The evidence base here primarily relies on Clinical Comparative Studies and observational reports, as opposed to large RCTs. Studies focused on measurements of lesion status and cosmetic appearance following intervention. Limited information exists for long-term outcomes regarding recurrence rates, as follow-up durations were often short-term.


Long-Term Data and Research Uncertainty

For all studied conditions, long-term effects are not fully established, as research monitoring recurrence typically extends to 6–12 months but rarely beyond one year. Comparative evidence is lacking for many complex scenarios, such as the most effective way to integrate cryotherapy with systemic topical therapies. Furthermore, data for certain groups, including individuals with certain underlying health conditions or widespread lesions, remain insufficient, highlighting areas where more controlled research is needed.

Key Studies & References

  1. Cryotherapy in Dermatology - StatPearls - NCBI Bookshelf
  2. Cryotherapy Patient Information Leaflet - University Hospitals Coventry and Warwickshire NHS Trust

Frequently Asked Questions (FAQ)

Common questions about Liquid Nitrogen (FAQ)

Q: Is Liquid Nitrogen the same as the nitrogen gas in the air we breathe?

A: The active component in the medical application is the element Nitrogen (N2), which is the same element that makes up a large portion of the air we breathe. However, the product is used in its refrigerated liquid state (LN2). Official regulatory requirements, such as the National Formulary (NF) designation, require it to meet high purity specifications for medical use.

Q: What makes Liquid Nitrogen a useful tool for treating skin conditions?

A: Its usefulness as a cryotherapy agent is directly related to its ultra-low temperature, which is approximately -196 C (-320 F). This physical property is used to cause destruction or modification of abnormal tissues through a rapid freezing process. Official medical information describes this as cryodestruction.

Q: Does Liquid Nitrogen require special storage conditions?

A: Yes, regulatory documents mandate that the product be stored in specialized cryogenic containers (Dewars) that allow for venting of evaporated gas. The containers are required to be kept upright and secured in well-ventilated areas that are not confined and are kept away from heat to maintain container integrity and patient safety.

Q: Are there any known interactions between Liquid Nitrogen treatment and my usual skin care products?

A: Official regulatory profiles do not include a dedicated section on drug or product interactions because the agent's action is non-systemic. Official guidance confirms no restrictions are mandated due to systemic interaction risk, which is consistent with the agent's non-systemic nature.

Q: Is it possible to receive Liquid Nitrogen treatment while pregnant or breastfeeding?

A: Official regulatory guidance indicates that use is generally considered acceptable during pregnancy and breastfeeding. Because its action is non-systemic, it is not absorbed, unlike medicines that circulate throughout the body.

Q: What does official guidance say about treating sensitive areas with Liquid Nitrogen?

A: Safety advisories note severe risks from contact with sensitive areas; for example, official warnings note the risk of permanent blindness from contact with the eyes. The decision to treat near sensitive sites requires careful consideration by the licensed practitioner, in line with official safety warnings. Additionally, treatment is prohibited for lesions in any area with compromised circulation.

Q: How does the temperature of Liquid Nitrogen affect the skin?

A: The extreme cold of the liquid or its cold vapor can cause rapid and severe tissue damage known as a cryogenic injury. Safety information describes this damage as similar to severe frostbite or cold burns, noting the risk of permanent injury or tissue loss.

Q: What kind of feeling should I expect when Liquid Nitrogen is applied?

A: Official patient information indicates that a stinging or burning sensation is commonly associated with the application. This discomfort usually starts to subside immediately after the procedure is complete.

Q: Can Liquid Nitrogen be used to treat things other than common warts?

A: Yes, the agent is recognized for use in treating a variety of skin lesions, including the destruction of precancerous skin lesions, such as actinic keratoses, and the treatment of certain benign growths, such as seborrheic keratosis. The purpose is to destroy or modify these abnormal lesions using the cryodestructive effect.

Q: Are there any reported long-term effects associated with Liquid Nitrogen application?

A: Official research notes that long-term effects beyond one year are not fully described, as study monitoring typically extends only to 6–12 months. Known risks documented in patient information include the potential for scarring and temporary or permanent changes in skin color (lighter or darker spots).

Q: How long after treatment should I expect to see the results?

A: The time it takes to see results varies depending on the lesion treated and its location. Generally, the treated area will blister and then form a scab, which usually peels away within 1 to 3 weeks. The need for repeat treatment is a decision made by the licensed practitioner.

Q: Is it common to have blistering or redness after treatment?

A: Yes, according to patient information, blister formation is a documented effect, and the treated area may look red afterward. This is part of the expected healing process after the application.

Q: Does the application of Liquid Nitrogen always require local anesthesia?

A: The procedure is typically quick. Official descriptive information notes that the health care provider may apply a numbing medicine (anesthesia) to the area first. The need for this is a determination made by the licensed practitioner based on the size and location of the lesion.

Q: Why is Liquid Nitrogen often described as a cryotherapy agent?

A: It is classified as a cryotherapeutic agent because its functional principle is achieved through the use of extreme cold (cryo-), specifically its ultra-low temperature, to destroy or modify targeted tissue.

Q: What happens if Liquid Nitrogen accidentally touches healthy skin?

A: Official safety warnings note that direct contact with the liquid or cold vapor can cause rapid, severe tissue damage, including cryogenic burns. First aid information for this type of injury is available in the official safety documents.

Q: Is the Liquid Nitrogen used in medicine the same purity as industrial-grade Liquid Nitrogen?

A: Medical-grade Liquid Nitrogen is required to meet the National Formulary (NF) purity specifications to ensure appropriate quality for human use. These standards require high purity (ge 99.0% Nitrogen with limits on contaminants) and ensure the quality required for human use.

Q: Are there different methods for applying Liquid Nitrogen to the skin?

A: Yes, according to descriptive clinical literature, the procedure can be performed using different devices. These commonly include application with a cotton swab or dipstick, a specialized metal probe that is cooled, or a dedicated cryospray device.

Q: Why do some people experience temporary changes in skin color after treatment?

A: Changes in skin color (hyperpigmentation or hypopigmentation) are documented as a potential risk of the procedure. These changes are sometimes observed if the application affected the deeper skin layers where pigment-producing cells are located.

Q: Is it possible to have a temporary loss of sensation in the treated area?

A: Yes, a temporary loss or reduction of sensation, known as local hypoaesthesia, is a documented potential risk of the procedure. This risk is noted, particularly in areas where the nerves are located close to the skin's surface.

Q: What should I know about the sensation of pain during and after the procedure?

A: Official patient information indicates that a stinging or burning sensation is commonly associated with the application. Afterwards, it is documented that mild pain or tenderness may occur for up to 3 days as the body begins the healing process.

Q: What kinds of reactions or sensitivities are known to interact with Liquid Nitrogen?

A: The primary sensitivities are related to cold itself. Use is contraindicated (must not be used) for patients with conditions exacerbated by cold, such as Cold Urticaria (cold-induced hives) and Cryoglobulinemia, as stated in official guidance.

Q: What is the role of Liquid Nitrogen in managing precancerous skin conditions?

A: It is used for the destruction of certain precancerous skin lesions, such as Actinic Keratosis (also known as solar keratoses). The purpose is to destroy or modify these abnormal lesions using the cryodestructive effect.

Q: Can Liquid Nitrogen be used on the face or near the eyes?

A: Official safety warnings note that use near the eyes carries a severe safety concern, including the risk of permanent blindness from contact with the liquid or cold vapor. The decision to treat other areas of the face requires careful consideration by the licensed practitioner.

Q: Why is the duration of application so important for a successful result?

A: Research indicates that outcomes are associated with the specific application technique used. This means that technical factors like the duration of the freeze-thaw cycle are important and influence the results observed in studies.

Q: How does the procedure differ when treating a large area versus a small one?

A: The procedure method can differ based on the size of the area. For small, localized spots, the agent may be applied using a cotton swab or probe. For more diffuse or larger lesions, a specialized cryospray device may be used.

Q: What research themes are commonly explored when studying Liquid Nitrogen use?

A: Common research themes include evaluating treatment protocols against other topical therapies, monitoring lesion status measurements, and investigating the influence of application technique, trial heterogeneity, and long-term recurrence rates for various conditions.

Q: What steps are generally advised after the Liquid Nitrogen application is finished?

A: General advice includes washing the area gently once or twice a day and keeping it clean. Bandaging or dressing is sometimes suggested if the area rubs against clothes or may be easily injured.

Q: Do official patient information leaflets mention anything about scars or marks from the procedure?

A: Yes, patient information documents mention scarring as a potential risk, especially if the freezing was prolonged or deeper skin areas were affected. The potential for temporary or permanent changes in skin color is also documented.

Q: Is there information on the potential for nerve irritation after treatment?

A: Yes, a documented potential risk is local hypoaesthesia (reduced sensation) due to nerve damage. This is considered a risk, particularly in areas where nerves are located close to the surface.

Q: How is the dose or quantity of Liquid Nitrogen controlled by the practitioner?

A: According to the official label, the dosage, application method, frequency, and duration of administration are all determined by the licensed practitioner who is experienced in its use. There is no fixed standard dosage provided on the product label.

Q: Can I apply makeup or moisturizer to the treated area right away?

A: General post-procedure advice is to wash the area gently and keep it clean. Specific use of topical products like makeup or moisturizer should align with instructions provided by the licensed practitioner.

How should Liquid Nitrogen be stored and disposed of?

Liquid Nitrogen ( N2), classified as a extbfCryogenic Liquid, is subject to strict official storage and disposal requirements mandated by governmental agencies to address the hazards of asphyxiation and pressure buildup. Storage extbfmust occur in extbfwell-ventilated areas that are extbfnot confined and extbfaway from heat to maintain container integrity and prevent oxygen displacement. Only extbfspecialized cryogenic containers (Dewars) that allow for extbfventing are permitted, and they extbfmust be secured in an extbfupright position. Tampering with pressure relief devices is extbfprohibited. Disposal of unused product extbfmust be carried out by extbfnatural evaporation in a safe, well-vented area. It is extbfprohibited to pour Liquid Nitrogen down extbfsink drains or into general waste, as this can cause structural damage. Storage areas must be extbfaccess-controlled and adhere to extbfchild-protection safety requirements.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Liquid Nitrogen found in:

A-Z Index: